Medications associated with hemophilia B
Ingredients whose current FDA labeling lists an association with hemophilia b, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Coagulation Factor Ix Recombinant Human
REBINYN, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA-derived coagulation Factor ...
Concizumab
Alhemo is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult a...
Etranacogene Dezaparvovec
HEMGENIX is indicated for treatment of adults with Hemophilia B (congenital Factor IX deficiency) who: Current...
Marstacimab
HYMPAVZI is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult...
Lab tests that investigate hemophilia b
CBC with Differential
Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...
Comprehensive Metabolic Panel (CMP)
Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...
Urinalysis
Examines urine content to help detect urinary tract infections, kidney disease, and diabetes....
Frequently Asked Questions
What medications are used for hemophilia b?
The medications listed above are associated with hemophilia b in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure hemophilia b?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.